Contemporary Management Of Stage T1 Transitional Cell Carcinoma Of The Bladder
- 1 April 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 167 (4) , 1573-1583
- https://doi.org/10.1016/s0022-5347(05)65157-9
Abstract
No abstract availableThis publication has 122 references indexed in Scilit:
- SECOND RESECTION AND PROGNOSIS OF PRIMARY HIGH RISK SUPERFICIAL BLADDER CANCER: IS CYSTECTOMY OFTEN TOO EARLY?Journal of Urology, 2001
- THE VALUE OF A SECOND TRANSURETHRAL RESECTION IN EVALUATING PATIENTS WITH BLADDER TUMORSJournal of Urology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Long‐term survival of patients with bladder tumours: the significance of risk factorsBritish Journal of Urology, 1998
- CORRELATION BETWEEN p53 OVER EXPRESSION AND RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY IN A HIGH RISK SELECT POPULATION OF PATIENTS WITH T1G3 BLADDER CANCERJournal of Urology, 1998
- Reassessment of Conservative Management for Stage T1N0M0 Transitional Cell Carcinoma of the BladderJournal of Urology, 1996
- Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapyCancer, 1994
- Multivariate Analysis of Progression in Superficial Bladder CancerBritish Journal of Urology, 1993
- Grading in Superficial Bladder Cancer. (1) Morphological CriteriaBritish Journal of Urology, 1988
- Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancerClinical Immunology and Immunopathology, 1986